BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10208176)

  • 21. Preimplantation diagnosis for fragile X syndrome based on the detection of the non-expanded paternal and maternal CGG.
    Sermon K; Seneca S; Vanderfaeillie A; Lissens W; Joris H; Vandervorst M; Van Steirteghem A; Liebaers I
    Prenat Diagn; 1999 Dec; 19(13):1223-30. PubMed ID: 10660959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plastic microchip electrophoresis for genetic screening: the analysis of polymerase chain reactions products of fragile X (CGG)n alleles.
    Sung WC; Lee GB; Tzeng CC; Chen SH
    Electrophoresis; 2001 Apr; 22(6):1188-93. PubMed ID: 11358146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of small FRAXA premutations.
    Francis D; Burgess T; Mitchell J; Slater H
    Mol Diagn; 2000 Sep; 5(3):221-5. PubMed ID: 11070156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies.
    Ryynänen M; Heinonen S; Makkonen M; Kajanoja E; Mannermaa A; Pertti K
    Eur J Hum Genet; 1999; 7(2):212-6. PubMed ID: 10196705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis of Martin-Bell syndrome based on an analysis of the structural-functional changes in the 5'-untranslated region of the FMR1 gene].
    Strel'nikov VV; Nemtsova MV; Chesnokova GG; Kuleshov NP; Zaletaev DV
    Mol Biol (Mosk); 1999; 33(2):330-6. PubMed ID: 10377581
    [No Abstract]   [Full Text] [Related]  

  • 26. Perspectives and molecular diagnosis of the fragile X syndrome.
    Brown WT
    Clin Lab Med; 1995 Dec; 15(4):859-75. PubMed ID: 8838227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue heterogeneity of the FMR1 mutation in a high-functioning male with fragile X syndrome.
    Taylor AK; Tassone F; Dyer PN; Hersch SM; Harris JB; Greenough WT; Hagerman RJ
    Am J Med Genet; 1999 May; 84(3):233-9. PubMed ID: 10331599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trinucleotide CGG repeat in the FMR1 gene in Chinese mentally retarded patients.
    Pang CP; Poon PM; Chen QL; Lai KY; Yin CH; Zhao Z; Zhong N; Lau CH; Lam ST; Wong CK; Brown WT
    Am J Med Genet; 1999 May; 84(3):179-83. PubMed ID: 10331586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal diagnosis of the fragile X syndrome: loss of mutation owing to a double recombinant or gene conversion event at the FMR1 locus.
    Losekoot M; Hoogendoorn E; Olmer R; Jansen CC; Oosterwijk JC; van den Ouweland AM; Halley DJ; Warren ST; Willemsen R; Oostra BA; Bakker E
    J Med Genet; 1997 Nov; 34(11):924-6. PubMed ID: 9391887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention of fragile X syndrome by prenatal genetic diagnosis: advantages and controversial aspects].
    Tejada MI
    Rev Neurol; 2001 Oct; 33 Suppl 1():S14-9. PubMed ID: 12447813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fragile X induction systems in CVS cultures: effect on cytogenetic, PCR, and genomic Southern Blot DNA analyses of the FMR-1 gene.
    Jenkins EC; Morys I; Henderson J; Genovese M; Carter M; Li SY; Houck GE; Ding X; Stark-Houck SL; Dobkin CS
    Am J Med Genet; 1994 Jul; 51(4):436-42. PubMed ID: 7943013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular diagnosis of Fragile X syndrome.
    Sofocleous C; Kolialexi A; Mavrou A
    Expert Rev Mol Diagn; 2009 Jan; 9(1):23-30. PubMed ID: 19099346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FMR1 premutations associated with fragile X-associated tremor/ataxia syndrome in multiple system atrophy.
    Biancalana V; Toft M; Le Ber I; Tison F; Scherrer E; Thibodeau S; Mandel JL; Brice A; Farrer MJ; Dürr A
    Arch Neurol; 2005 Jun; 62(6):962-6. PubMed ID: 15956167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct mutation analysis of 495 patients for fragile X carrier status/proband diagnosis.
    Kaplan G; Kung M; McClure M; Cronister A
    Am J Med Genet; 1994 Jul; 51(4):501-2. PubMed ID: 7943028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiplex methylation specific PCR analysis of fragile X syndrome: experience in Songklanagarind Hospital.
    Charalsawadi C; Sripo T; Limprasert P
    J Med Assoc Thai; 2005 Aug; 88(8):1057-61. PubMed ID: 16404832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pilot study for the neonatal screening of fragile X syndrome.
    Rifé M; Mallolas J; Badenas C; Tazón B; Miguélez MR; Pàmpols T; Sànchez A; Milà M
    Prenat Diagn; 2002 Jun; 22(6):459-62. PubMed ID: 12116303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal genetic testing: full clinical information is needed.
    Harraway J
    N Z Med J; 2005 May; 118(1215):U1468. PubMed ID: 15915189
    [No Abstract]   [Full Text] [Related]  

  • 38. [Molecular diagnosis of fragile X syndrome with polymerase chain reaction: application of a diagnostic protocol in 50 families from northern Spain].
    Durán Domínguez M; Molina Carrillo M; Fernández Toral J; Martínez Merino T; López Arístegui MA; Alvarez Retuerto AI; Onaindía Urquijo ML; Tejada Mínguez MI
    An Esp Pediatr; 2001 Apr; 54(4):331-9. PubMed ID: 11273816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenatal diagnosis of fragile X syndrome by direct detection of the unstable DNA sequence.
    Sutherland GR; Gedeon A; Kornman L; Donnelly A; Byard RW; Mulley JC; Kremer E; Lynch M; Pritchard M; Yu S
    N Engl J Med; 1991 Dec; 325(24):1720-2. PubMed ID: 1944473
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prenatal diagnosis in a family carrying the fragile X syndrome using recombinant DNA technics].
    Benítez J; Fernández E; Ramos C; Nunes V; del Río E; Baiget M
    Rev Clin Esp; 1989 Apr; 184(7):364-6. PubMed ID: 2570446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.